Abstract:Early childhood caries is a severe oral disease that results in aggressive tooth decay. Particularly, a synergistic association between a fungus, Candida albicans, and a cariogenic bacterium, Streptococcus mutans, promotes the development of hard-to-remove and highly acidic biofilms, exacerbating the virulent damage. These interactions are largely mediated via glucosyltransferases (GtfB) binding to mannans on the cell wall of C. albicans Here, we present an enzymatic approach to target GtfB-mannan interactions in this cross-kingdom consortium using mannan-degrading exo- and endo-enzymes. These exo- and endo-enzymes are highly effective in reducing biofilm biomass without killing microorganisms, as well as alleviating the production of an acidic pH environment conducive to tooth decay. To corroborate these results, we present biophysical evidence using single-molecule atomic force microscopy, biofilm shearing, and enamel surface topography analyses. Data show a drastic decrease in binding forces of GtfB to C. albicans (∼15-fold reduction) following enzyme treatment. Furthermore, enzymatic activity disrupted biofilm mechanical stability and significantly reduced human tooth enamel demineralization without cytotoxic effects on gingival keratinocytes. Our results represent significant progress toward a novel nonbiocidal therapeutic intervention against pathogenic bacterial-fungal biofilms by targeting the interkingdom receptor-ligand binding interactions.IMPORTANCE Biofilm formation is a key virulence factor responsible for various infectious diseases. Particularly, interactions between a fungus, Candida albicans, and a bacterium, Streptococcus mutans, have been known to play important roles in the pathogenesis of dental caries. Although some antimicrobials have been applied to treat fungal-involved biofilm-associated diseases, these often lack targeting polymicrobial interactions. Furthermore, these may not be appropriate for preventive measures because these antimicrobials may disrupt ecological microbiota and/or induce the prevalence of drug resistance over time. By specifically targeting the interaction mechanism whereby mannoproteins on the C. albicans surface mediate the cross-kingdom interaction, we demonstrated that mannoprotein-degrading enzymes can effectively disrupt biofilm interactions without microbiocidal effects or causing cytotoxicity to human cells. This suggests a potential application as a targeted approach for intervening a pathogenic cross-kingdom biofilm associated with a costly and unresolved oral disease.

Tetrahedral framework nucleic acid–based small‐molecule inhibitor delivery for ecological prevention of biofilm

Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence

A Novel Small Molecule, LCG-N25, Inhibits Oral Streptococcal Biofilm

NIR-activated nanosystems with self-modulated bacteria targeting for enhanced biofilm eradication and caries prevention

Intervening in Symbiotic Cross-Kingdom Biofilm Interactions: a Binding Mechanism-Based Nonmicrobicidal Approach

A new small molecule inhibits streptococcus mutans biofilms in vitro and in vivo

Polymer vesicles for the delivery of inhibitors of cariogenic biofilm

Targeting Ofstreptococcus Mutansbiofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiome

Microenvironment‐Regulating Drug Delivery Nanoparticles for Treating and Preventing Typical Biofilm‐Induced Oral Diseases

Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic Virulence

A novel small molecule ZY354 inhibits dental caries-associated oral biofilms.

Molecule Targeting Glucosyltransferase Inhibits Streptococcus Mutans Biofilm Formation and Virulence

Drug-loaded adhesive microparticles for biofilm prevention on oral surfaces

Regulating Oral Biofilm from Cariogenic State to Non-Cariogenic State via Novel Combination of Bioactive Therapeutic Composite and Gene-Knockout

Lactobacillus cell envelope-coated nanoparticles for antibiotic delivery against cariogenic biofilm and dental caries

Small molecule inhibitors for Streptococcus mutans biofilms

Function-adaptive clustered nanoparticles reverse Streptococcus mutans dental biofilm and maintain microbiota balance

Precision targeting of bacterial pathogen via bi-functional nanozyme activated by biofilm microenvironment

A New Small Molecule Specifically Inhibits the Cariogenic Bacterium Streptococcus Mutans in Multispecies Biofilms

Novel Approaches to the Control of Oral Microbial Biofilms

Discovery of Potent Inhibitors of <i>Streptococcus mutans</i> Biofilm with Antivirulence Activity